All Substitutes
Loading...
Disclaimer
Did you find this information helpful?
Soranamo 200mg Tablet
Prescription Required
Salt Composition : Sorafenib
Manufacturer : SHIVNAAM TRADELINK LLP
Origin of Medicine : India
120 Tablet(s) In A Bottle
Introduction to Soranamo 200mg Tablet
Soranamo 200mg Tablet belongs to the class of cancer medications known as multikinase inhibitors containing the active ingredient sorafenib. Soranamo 200mg Tablet is a medication primarily used in the treatment of advanced renal cell carcinoma (kidney cancer), hepatocellular carcinoma (liver cancer), and thyroid cancer.
It is not recommended to take Soranamo 200mg Tablet if you are allergic to the active compound and other ingredients of the medicine. Speak with your doctor immediately if you experience skin rashes, heart problems, chest pain, bleeding problems, high blood pressure, or have had or are about to have surgery. It is not recommended for use in children and adolescents. Patients with diabetes should have their blood sugar levels examined frequently to see whether the dosage of anti-diabetic medications needs to be changed to reduce the risk of low blood sugar. Your doctor will monitor liver function tests, fluid and electrolyte balance to help identify and manage potential side effects promptly.
It is not advised to use this medication while pregnant since it may harm the fetus Therefore, for women of reproductive age, it is recommended to get a pregnancy test before beginning this medication. It is preferable to keep using birth control for at least six months after treatment is finished. While receiving treatment, it is not advised to breastfeed your child because this medication might affect your baby's growth and development. This treatment may affect the fertility in both men and women, it is advised to consult your doctor before starting the therapy.
It is necessary to inform your doctor about all the medicines you are taking including prescription, over the counter drugs, vitamins and supplements.
Uses of Soranamo 200mg Tablet
- Advanced renal cell carcinoma
- Advanced hepatocellular carcinoma
- Differentiated thyroid carcinoma
Therapeutic Effects of Soranamo 200mg Tablet
Soranamo 200mg Tablet works by inhibiting multiple protein kinases involved in tumor cell proliferation and angiogenesis (the formation of new blood vessels that supply tumors). Specifically, it targets receptors for vascular endothelial growth factor (VEGF), platelet-derived growth factor (PDGF), and Raf kinases, which play key roles in cancer development and progression. This stops the growth and spread of the tumor cells to other organs, as well the formation of blood vessels in the tumor cells.
Interaction of Soranamo 200mg Tablet with other drugs
Inform your healthcare provider about all the medicines you take, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products. Certain medications may interact with Soranamo 200mg Tablet and reduce effectiveness by causing undesirable side effects.
More Information about Soranamo 200mg Tablet
- Store Soranamo 200mg Tablet in the original package at room temperature (20°C to 25°C).
- Keep it out of reach from children
How to consume Soranamo 200mg Tablet
The medicine will be prescribed to you by a healthcare professional in a hospital setting. It is not recommended to take this medication with meals that are high in fat since this may reduce Soranamo 200mg Tablet's effectiveness. Take the pills at least one hour before or two hours after a high-fat meal if you plan to eat one.
The dose will be decided by your healthcare professional based on your conditions. Avoid crushing, opening, or dissolving the tablet and swallow it whole with a glass of water. Take the Soranamo 200mg Tablet at the same time every day.
Safety Advices for Soranamo 200mg Tablet
Pregnancy
It is not recommended to take Soranamo 200mg Tablet during pregnancy as it may harm your unborn baby. It is necessary to inform your doctor if you are pregnant or planning to become pregnant
Breast Feeding
It is unknown whether Soranamo 200mg Tablet passes into the breast milk. It is not recommended that a child be nursed during therapy. This medication might affect your baby's growth and development. Please consult your doctor before breastfeeding.
Lungs
Consult your doctor if you have any lung diseases before starting the treatment with Soranamo 200mg Tablet.
Liver
It is unknown whether Soranamo 200mg Tablet is safe in individuals with liver disorders. Inform your physician if you have any liver problems before starting the treatment.
Alcohol
Alcohol consumption can lead to hepatotoxicity and might alter the metabolism of Soranamo 200mg Tablet. Please consult your doctor for more advice.
Driving
There is no proof that Soranamo 200mg Tablet will impair one's capacity to operate machinery or drive a car. However, if you experience any of the side effects like dizziness, or fatigue, it is not advised to drive or operate heavy machinery.
Side Effects of Soranamo 200mg Tablet
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.
Common:
- Nausea
- Vomiting
- Fatigue
- Diarrhoea
- Alopecia
- Hand foot skin reaction
- Gut wall bleeding
Serious:
- gastrointestinal perforation
- abnormal heart rhythm (QT prolongation)
- inflammation of the liver
- breathing or swallowing difficulties
- Stevens Johnsons Syndrome and toxic epidermal necrolysis
- Decreased blood flow to the heart
- Increased risk of bleeding (blood in urine, stool, vomit, cough, etc)
Word of Advice
Follow all instructions and dosing recommendations provided by your healthcare provider. Do not take more or less of the medication than prescribed. Report any new or worsening symptoms to your healthcare provider immediately, especially if they relate to your lungs, eyes, skin, liver, kidneys, heart, or bleeding. When undergoing this therapy, stay out of direct sunlight and wear sunscreen with an SPF of at least 50 before going outside.
Soranamo 200mg Tablet should not be stopped without first talking to your doctor. Even if you feel better or see a change in your symptoms, you should still talk to your doctor before stopping Soranamo 200mg Tablet. It is recommended to inform your doctor about other anticancer drugs you have been taking. It's critical to maintain a sufficient fluid intake because dehydration can exacerbate symptoms such as diarrhea and other gastrointestinal disorders. Remember to attend all scheduled appointments and follow-up visits with your healthcare provider to ensure your treatment is effective and any side effects are managed appropriately.
FAQs
Q 1. Will Soranamo 200mg Tablet cause hair loss?
Alopecia, or hair thinning or loss, is a possible adverse effect of Soranamo 200mg Tablet therapy, however it is less frequent than with certain other chemotherapy medications. While using Soranamo 200mg Tablet, not every patient will experience hair loss, and each patient's level of hair thinning will differ.
Q 2. Can individuals with diabetes take Soranamo 200mg Tablet?
The decision to use Soranamo 200mg Tablet in individuals with diabetes should be made on a case-by-case basis. Soranamo 200mg Tablet may affect blood glucose levels, and individuals with diabetes may experience changes in glycemic control while taking the medication.
Q 3. For what duration must You take Soranamo 200mg Tablet?
The length of Soranamo 200mg Tablet treatment varies based on patient-specific factors such tolerability, treatment response, and cancer kind and stage. While some individuals would only need Soranamo 200mg Tablet for a few months, others might need ongoing care. The length of treatment that is right for you will be decided by your healthcare practitioner based on your particular circumstance
Q 4. What should you not take with Soranamo 200mg Tablet?
It is not recommended to eat foods high in fat content while on treatment with Soranamo 200mg Tablet. Tell your healthcare provider before taking Soranamo 200mg Tablet if you are taking any prescription medicines, over the counter drugs, vitamins or herbal supplements.
Fact Box of Soranamo 200mg Tablet
Molecule Name: Sorafenib
| Therapeutic class: Antineoplastics |
Pharmacological class: Multikinase inhibitors | Indications: 1. Advanced renal cell carcinoma 2. Advanced hepatocellular carcinoma 3. Differentiated thyroid carcinoma |
Dosage form: Tablets
| Habit forming: No |
References
- Bayer (Pty) Ltd, [Revised on 22nd Apr 2016] [Accessed on 15th March 2024], https://www.bayer.com/sites/default/files/NEXAVAR_200_EN_PI.pdf
- Bayer HealthCare Pharmaceuticals Inc., US Food & Drug Administration, [Revised on Dec 2018] [Accessed on 15th March 2024]], https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021923s020lbl.pdf
- Bayer AG, European Medicines Compendium (emc), [Revised on April 2023], [Accessed on 15th March 2024], https://www.medicines.org.uk/emc/files/pil.226.pdf
- Zentiva Pharma UK Limited, Medicines Compendium (emc), [Revised on April 2022], [Accessed on 15th March 2024] https://www.medicines.org.uk/emc/files/pil.13098.pdf
- KD Tripathi, Anticancer Drugs, Essentials of Medical Pharmacology, 8th Edition, 2019, 915-936.
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that experts, accurate and trustworthy, review. The information and contents of this website are for informational purposes only. They are not intended to substitute for professional medical advice, diagnosis, or treatment. Please seek your doctor's advice and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.